Piperidine and piperazine derivatives

US8791111B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Kai Schiemann · Darmstadt, DE
• Melanie Schultz · Darmstadt, DE
• Andree Blaukat · Heilbad Heiligenstadt, DE
• Ingo Kober · Groß-Gerau, DE

Key dates

• Filing date: Sep 19, 2008
• Grant date: Jul 29, 2014
• Expiry date: Apr 3, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula (I), in which R1, R2, R3, D, G, Q and W have the meanings indicated in Claim (1), can and be employed for the treatment of tumors.